Antidote for opioid poisoning:
The drug of choice for hyperthyroidism in third trimester of pregnancy is:
Which of the following local anesthetics is the most common cause of methemoglobinemia?
Which drug is used as a spermicidal cream in contraceptives?
Which of the following anti-diabetic drugs is associated with weight gain?
Which of the following anti-epileptic drugs has the highest teratogenic potential?
Therapeutic drug monitoring is done for:
Antidote for benzodiazepine poisoning: FMGE 10, 13; NEET 14
Which of the following is NOT used for iron poisoning?
All are features of organophosphorus poisoning, except:
Explanation: ***Naloxone*** - **Naloxone** is a pure **opioid antagonist** that reverses the effects of opioid overdose by competing for and binding to opioid receptors. - It is crucial in emergent situations to restore **respiratory drive** and consciousness in patients with opioid-induced respiratory depression. *Pethidine* - **Pethidine** is an **opioid analgesic** itself, primarily used for pain management, and would worsen opioid poisoning. - It works by binding to opioid receptors, leading to centrally mediated pain relief, making it contraindicated in overdose. *Flumazenil* - **Flumazenil** is an antagonist for **benzodiazepines**, used to reverse their sedative and respiratory depressant effects. - It has no effect on opioid receptors and would not be effective in treating opioid poisoning. *Physostigmine* - **Physostigmine** is a **cholinesterase inhibitor** used to reverse anticholinergic toxicity. - It increases acetylcholine levels at the synapse and is not indicated for opioid overdose.
Explanation: ***Carbimazole*** - **Carbimazole** (metabolized to methimazole) is the **drug of choice in the third trimester** of pregnancy for managing hyperthyroidism. - The teratogenic risk of methimazole/carbimazole is confined to the **first trimester** (embryopathy includes aplasia cutis, choanal atresia, esophageal atresia). By the third trimester, organogenesis is complete and this risk has passed. - **Propylthiouracil (PTU)** is associated with severe **hepatotoxicity**, which is why current guidelines recommend switching from PTU to methimazole/carbimazole after the first trimester. - Both drugs cross the placenta, but in the third trimester, the safety profile favors carbimazole over PTU. *Propylthiouracil* - **PTU** is preferred only in the **first trimester** to avoid methimazole-associated congenital anomalies during the critical period of organogenesis. - After the first trimester, patients should be switched to methimazole/carbimazole due to PTU's risk of severe **hepatotoxicity** (including fulminant hepatic failure requiring transplantation). - PTU is not the drug of choice for the third trimester despite having lower placental transfer. *Sodium iodide* - **Sodium iodide** is used acutely in **thyroid storm** or as preoperative preparation for thyroidectomy, not for chronic management of hyperthyroidism. - Prolonged use can cause the **Wolff-Chaikoff effect** (temporary inhibition of thyroid hormone synthesis) followed by escape phenomenon and worsening hyperthyroidism. - Can cause fetal goiter and hypothyroidism with chronic use, making it unsuitable for long-term pregnancy management. *Radioactive iodine* - **Radioactive iodine** is **absolutely contraindicated** in pregnancy at any stage. - It crosses the placenta after 10-12 weeks of gestation and destroys the fetal thyroid gland, causing permanent **fetal hypothyroidism** and **cretinism**. - Must be avoided in pregnancy; pregnancy should be excluded before radioactive iodine therapy.
Explanation: ***Benzocaine***- **Benzocaine** is an ester-type local anesthetic that is the **most common cause of methemoglobinemia** among local anesthetics, especially when used in high doses or on mucous membranes due to its rapid absorption.- Its metabolic byproducts, particularly **aniline derivatives**, are potent oxidizers of hemoglobin, converting the ferrous iron (Fe2+) to ferric iron (Fe3+), thus forming methemoglobin which cannot bind oxygen.- **FDA warnings** have been issued regarding benzocaine-induced methemoglobinemia, particularly with topical spray preparations.*Lignocaine*- **Lignocaine** (lidocaine) is an amide-type local anesthetic and is **rarely associated** with methemoglobinemia.- While it can theoretically cause it in very high doses, it is significantly **less potent** in this regard compared to benzocaine.*Chloroprocaine*- **Chloroprocaine** is an ester-type local anesthetic with a very **short duration of action** due to rapid hydrolysis by plasma cholinesterases.- This rapid metabolism typically limits systemic exposure and makes it an **uncommon cause** of methemoglobinemia despite being an ester.*Prilocaine*- **Prilocaine** is an amide-type local anesthetic that can also cause methemoglobinemia, particularly at **higher doses (>600mg)** [1, 2].- It works through its metabolite, **o-toluidine**, which is an oxidizing agent [1].- However, **benzocaine** is more consistently linked to this adverse effect in clinical practice and has more documented case reports.
Explanation: **Nonoxynol-9** - **Nonoxynol-9** is a common **spermicide** used in many contraceptive products like creams, foams, and gels. - It works by damaging the **sperm cell membrane**, effectively immobilizing and killing sperm. *Gossypol* - **Gossypol** is a natural compound found in cotton plants that has been studied for its potential as a **male contraceptive**. - It works by inhibiting **spermatogenesis** but has not been approved for widespread use due to toxicity concerns like **hypokalemia**. *Clomiphene* - **Clomiphene** is a **selective estrogen receptor modulator (SERM)** used to induce ovulation in women who are infertile due to anovulation. - It stimulates the release of **gonadotropins** (FSH and LH) from the pituitary gland, leading to follicular development. *Centchroman* - **Centchroman** (also known as Ormeloxifene) is a **non-steroidal oral contraceptive** used in India. - It acts as a **selective estrogen receptor modulator** in the uterus, disrupting the implantation process.
Explanation: ***Pioglitazone*** - **Pioglitazone**, a **thiazolidinedione**, primarily works by improving insulin sensitivity in peripheral tissues. - Its mechanism of action can lead to **fluid retention** and **increased subcutaneous fat storage**, both contributing to weight gain. *Acarbose* - **Acarbose** is an **alpha-glucosidase inhibitor** that delays carbohydrate absorption in the gut. - This mechanism typically leads to a **neutral effect or slight weight loss**, as fewer calories are rapidly absorbed. *Metformin* - **Metformin**, a **biguanide**, reduces hepatic glucose production and improves insulin sensitivity. - It is often associated with **weight neutrality or modest weight loss**, and is not known to cause weight gain. *Sitagliptin* - **Sitagliptin** is a **dipeptidyl peptidase-4 (DPP-4) inhibitor** that enhances incretin effects. - This class of drugs is generally considered **weight-neutral** and rarely causes weight gain.
Explanation: ***Correct: Valproate*** - **Valproate has the highest teratogenic potential** among all anti-epileptic drugs, with a **10-20% risk of major congenital malformations** - **Neural tube defects** (spina bifida) occur in **1-2% of exposed pregnancies**, which is 10-20 times higher than the general population - Other significant risks include **cardiac malformations, craniofacial abnormalities**, and **neurodevelopmental disorders** (autism spectrum disorder, reduced IQ) - **Fetal valproate syndrome** is a recognized clinical entity - Current guidelines strongly recommend **avoiding valproate in women of childbearing potential** unless no alternatives exist *Incorrect: Carbamazepine* - Has teratogenic risks but significantly **lower than valproate** (2-5% risk of major malformations) - Associated with **neural tube defects** (0.5-1% risk, lower than valproate) - Considered a safer alternative when valproate must be avoided *Incorrect: Phenytoin* - Causes **fetal hydantoin syndrome** with characteristic features: craniofacial anomalies, nail/digital hypoplasia, growth restriction, and developmental delay - Teratogenic risk is **moderate** (approximately 5-10% risk of major malformations) - Risk is significant but **lower than valproate** *Incorrect: Lamotrigine* - Considered **one of the safest anti-epileptic drugs** during pregnancy - Low teratogenic risk with **major malformation rate of 2-3%** (close to baseline population risk) - Slight increased risk of **oral clefts** at higher doses - **Preferred choice** for women of childbearing potential requiring anti-epileptic therapy
Explanation: ***Phenytoin*** - **Phenytoin** has a **narrow therapeutic window**, meaning the difference between an effective and a toxic dose is small, necessitating close monitoring. - Its **variable absorption** and **nonlinear pharmacokinetics** (saturable metabolism) make individual dosing adjustments critical to maintain therapeutic levels and avoid toxicity. *Aspirin* - **Aspirin** is generally not monitored via plasma levels for its analgesic or antiplatelet effects, as its therapeutic effects are often observed at doses where plasma monitoring is not practical or necessary. - Its primary therapeutic use as an **antiplatelet agent** is evaluated by clinical outcomes rather than drug concentration. *Heparin* - **Heparin** is monitored using coagulation tests like **aPTT (activated partial thromboplastin time)** or anti-Xa levels to assess its anticoagulant effect, not direct drug concentration. - Therapeutic drug monitoring for heparin focuses on its **pharmacodynamic effects** on the clotting cascade rather than its absolute plasma concentration. *Metformin* - **Metformin** has a relatively **wide therapeutic index** and its efficacy is primarily measured by reductions in blood glucose and HbA1c, not by plasma drug concentrations. - It is excreted largely unchanged by the kidneys, and dose adjustments are typically made based on **renal function** and glycemic control.
Explanation: ***Flumazenil*** - **Flumazenil** is a competitive **benzodiazepine receptor antagonist** that can reverse the sedative and other central nervous system effects of benzodiazepines. - It works by blocking benzodiazepines from binding to their receptor sites on the **GABA-A receptor complex**. *Naloxone* - **Naloxone** is a competitive **opioid receptor antagonist** used to reverse opioid overdose. - It has no effect on **benzodiazepine toxicity** as it targets different receptor systems. *Atropine* - **Atropine** is an **anticholinergic drug** used to reverse the effects of **cholinergic poisoning** (e.g., from organophosphates, carbamates) or symptomatic bradycardia. - It works on muscarinic acetylcholine receptors and is not involved in benzodiazepine metabolism or action. *N-acetyl-cysteine* - **N-acetyl-cysteine (NAC)** is primarily used as an antidote for **acetaminophen (paracetamol) poisoning**, where it replenishes glutathione. - It is also used in some cases of mucolysis but has no role in reversing benzodiazepine toxicity.
Explanation: ***Penicillamine*** - **Penicillamine** is a chelating agent indicated for **copper poisoning** (Wilson's disease), **lead poisoning**, and **rheumatoid arthritis**, but has **no role in iron poisoning**. - It works by chelating copper, lead, and other heavy metals, but does not effectively chelate iron. - This is the most clearly incorrect option as it is never indicated for iron toxicity. *EDTA (Ethylenediaminetetraacetic acid)* - **EDTA** is primarily used for **lead poisoning** and hypercalcemia. - While not routinely used for iron poisoning, it can form iron-EDTA complexes, which may paradoxically worsen toxicity. - **CaNa₂EDTA** is avoided in iron poisoning due to potential complications. *Desferrioxamine* - **Desferrioxamine (Deferoxamine)** is the **first-line antidote** for severe iron poisoning. - It is a highly specific iron-chelating agent that binds free iron in the bloodstream and promotes its renal excretion as ferrioxamine. - It reduces iron-mediated oxidative damage to organs (especially liver, heart, and GI tract). *Gastric lavage* - **Gastric lavage** can be used as a decontamination method in acute iron poisoning if performed early (within 1-2 hours of ingestion). - It helps remove unabsorbed iron tablets from the stomach, reducing further systemic absorption. - Whole bowel irrigation with polyethylene glycol is often preferred for iron tablet ingestion.
Explanation: ***Mydriasis*** - Organophosphorus poisoning leads to excessive **acetylcholine** activity, causing **miosis** (pinpoint pupils), not mydriasis. - Mydriasis would indicate **anticholinergic** effects, which are opposite to the symptoms of organophosphorus poisoning. *Lacrimation* - Excess **acetylcholine** stimulates **muscarinic receptors** in lacrimal glands, leading to excessive tear production. - This is a classic "SLUDGE" symptom (Salivation, Lacrimation, Urination, Defecation, Gastric upset, Emesis). *Bradycardia* - Increased **acetylcholine** activity at cardiac muscarinic receptors (M2 receptors) slows the heart rate, causing **bradycardia**. - This is a common and potentially dangerous cardiovascular effect of organophosphorus poisoning. *Sweating* - **Acetylcholine** acts on muscarinic receptors in secretory glands, including sweat glands, causing profuse **sweating**. - This is another characteristic cholinergic symptom due to widespread autonomic overstimulation.
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free